+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Healthcare costs associated with cardiovascular events in patients with hyperlipidemia or prior cardiovascular events: estimates from Swedish population-based register data



Healthcare costs associated with cardiovascular events in patients with hyperlipidemia or prior cardiovascular events: estimates from Swedish population-based register data



European Journal of Health Economics 17(5): 591-601



To estimate healthcare costs of new cardiovascular (CV) events (myocardial infarction, unstable angina, revascularization, ischemic stroke, transient ischemic attack, heart failure) in patients with hyperlipidemia or prior CV events. A retrospective population-based cohort study was conducted using Swedish national registers and electronic medical records. Patients with hyperlipidemia or prior CV events were stratified into three cohorts based on CV risk level: history of major cardiovascular disease (CVD), coronary heart disease (CHD) risk-equivalent, and low/unknown risk. Propensity score matching was applied to compare patients with new events to patients without new events for estimation of incremental costs of any event and by event type. A CV event resulted in increased costs over 3 years of follow-up, with the majority of costs occurring in the 1st year following the event. The mean incremental cost of patients with a history of major CVD (n = 6881) was €8588 during the 1st year following the event. This was similar to that of CHD risk-equivalent patients (n = 3226; €6663) and patients at low/unknown risk (n = 2497; €8346). Ischemic stroke resulted in the highest 1st-year cost for patients with a history of major CVD and CHD risk-equivalent patients (€10,194 and €9823, respectively); transient ischemic attack in the lowest (€3917 and €4140). Incremental costs remained elevated in all cohorts during all three follow-up years, with costs being highest in the major CVD history cohort. Healthcare costs of CV events are substantial and vary considerably by event type. Incremental costs remain elevated for several years after an event.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 057973152

Download citation: RISBibTeXText

PMID: 26077550

DOI: 10.1007/s10198-015-0702-0


Related references

Health Care Costs Associated With Cardiovascular Events In Patients With Hyperlipidemia - Estimates From Population-Based Register Data In Sweden. Value in Health 17(7): A492, 2014

Work productivity loss and indirect costs associated with new cardiovascular events in high-risk patients with hyperlipidemia: estimates from population-based register data in Sweden. European Journal of Health Economics 17(9): 1117-1124, 2016

Work Productivity Loss and Indirect Costs Associated with New Cardiovascular Events in High-Risk Patients with Hyperlipidemia - Estimates from Population-Based Register Data in Sweden. Value in Health 17(7): A327, 2014

Treatment Patterns in Hyperlipidemia Patients With New Cardiovascular Events - Estimates From Population-Based Register Data in Sweden. Value in Health 17(7): A501, 2014

Lipid-lowering treatment patterns in patients with new cardiovascular events - estimates from population-based register data in Sweden. International Journal of Clinical Practice 70(3): 222-228, 2016

Cardiovascular event rates in a high atherosclerotic cardiovascular disease risk population: estimates from Swedish population-based register data. European Heart Journal. Quality of Care and Clinical Outcomes 5(3): 225-232, 2019

A Retrospective Study to Examine Healthcare Costs Related to Cardiovascular Events in Individuals with Hyperlipidemia. Advances in Therapy 32(11): 1104-1116, 2015

Risk Of Major Cardiovascular Events In Patients With Type 2 Diabetes With And Without Prior Cardiovascular Events: Results From The Leader Trial. Canadian Journal of Cardiology 33(10): S126-S127, 2017

Medical costs associated with cardiovascular events among high-risk patients with hyperlipidemia. Clinicoeconomics and Outcomes Research 7: 337-345, 2015

Towards renewed health economic simulation of type 2 diabetes: risk equations for first and second cardiovascular events from Swedish register data. Plos one 8(5): E62650, 2013

Albuminuria and renal function as predictors of cardiovascular events and mortality in a general population of patients with type 2 diabetes: a nationwide observational study from the Swedish National Diabetes Register. Diabetes and Vascular Disease Research 10(6): 520-529, 2013

Sp459Both Low And High Systolic Blood Pressure Increases The Risk Of Cardiovascular Events And All-Cause Of Mortality In Patients With Type 2-Diabetes And Renal Impairment Without Previous Cardiovascular Disease Or Congestive Heart Failure- The Swedish National Diabetes Register (Ndr). Nephrology Dialysis Transplantation 30(Suppl_3): iii 531-iii 532, 2015

Ldl-C Goal Attainment In Patients With Hyperlipidemia - Estimates From Population-Based Register Data In Sweden. Value in Health 17(7): A497, 2014

Aspirin and the risk of cardiovascular events in atherosclerosis patients with and without prior ischemic events. Clinical Cardiology 40(9): 732-739, 2017

Physicians estimates of the risk of cardiovascular events and their decisions to use pharmacological therapy for hyperlipidemia. JGIM 14(Suppl. 2): 117, 1999